Literature DB >> 24720519

Enhanced bone regeneration with a novel synthetic bone substitute in combination with a new natural cross-linked collagen membrane: radiographic and histomorphometric study.

José Luis Calvo-Guirado1, Maria P Ramírez-Fernández1, Jose E Maté-Sánchez1, Negri Bruno1, Pablo Velasquez2, Piedad N de Aza2.   

Abstract

OBJECTIVES: 4Bone is a fully synthetic bioactive bone substitute composed of 60% hydroxyapatite (HA) and 40% beta-tricalcium phosphate (ß-TCP). This study aimed to investigate the effect of resorbable collagen membranes (RCM) on critical size defects in rabbit tibiae filled with this novel biphasic calcium phosphate at 15, 30, 45, and 60 days by radiological and histomorphometric analysis.
MATERIAL AND METHODS: Three critical size defects of 6 mm diameter were created in both tibiae of 20 New Zealand rabbits and divided into three groups according to the filling material: Group A (4Bone), Group B (4Bone plus RCM), and Group C (unfilled control group). At each of the four study periods, five rabbits were sacrificed. Anteroposterior and lateral radiographs were taken. Samples were processed for observation under light microscopy.
RESULTS: At the end of treatment, radiological analysis found that cortical defect closure was greater in Group B than Group A, and radiopacity was clearly lower and more heterogeneous in Group A cortical defects than in Group B. There was no cortical defect closure in Group C. Histomorphometric evaluation showed significant differences in newly formed bone and cortical closure in Group B compared with Groups A and C, with the presence of higher density newly formed bone in cortical and medullar zones.
CONCLUSIONS: Biphasic calcium phosphate functioned well as a scaffolding material allowing bone ingrowth and mineralization. The addition of absorbable collagen membranes enhanced bone gain compared with non-membrane-treated sites. This rabbit study provides radiological and histological evidence confirming the suitability of this new material for guided tissue regeneration of critical defects.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bone substitute; collagen membrane; critical size defects; guided bone regeneration; hydroxyapatite; tricalcium phosphate

Mesh:

Substances:

Year:  2014        PMID: 24720519     DOI: 10.1111/clr.12399

Source DB:  PubMed          Journal:  Clin Oral Implants Res        ISSN: 0905-7161            Impact factor:   5.977


  5 in total

1.  Rehabilitation of the severely atrophied dentoalveolar ridge in the aesthetic region with corticocancellous grafts from the iliac crest and dental implants.

Authors:  M Lehmijoki; H Holming; H Thorén; P Stoor
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-09-01

2.  Morphological and Structural Study of a Novel Porous Nurse's A Ceramic with Osteoconductive Properties for Tissue Engineering.

Authors:  Ruben Rabadan-Ros; Pablo A Velásquez; Luis Meseguer-Olmo; Piedad N De Aza
Journal:  Materials (Basel)       Date:  2016-06-15       Impact factor: 3.623

3.  SEM-EDX Study of the Degradation Process of Two Xenograft Materials Used in Sinus Lift Procedures.

Authors:  María Piedad Ramírez Fernández; Sergio A Gehrke; Carlos Pérez Albacete Martinez; Jose L Calvo Guirado; Piedad N de Aza
Journal:  Materials (Basel)       Date:  2017-05-17       Impact factor: 3.623

Review 4.  Mineralized Collagen: Rationale, Current Status, and Clinical Applications.

Authors:  Zhi-Ye Qiu; Yun Cui; Chun-Sheng Tao; Zi-Qiang Zhang; Pei-Fu Tang; Ke-Ya Mao; Xiu-Mei Wang; Fu-Zhai Cui
Journal:  Materials (Basel)       Date:  2015-07-24       Impact factor: 3.623

5.  Study of Two Bovine Bone Blocks (Sintered and Non-Sintered) Used for Bone Grafts: Physico-Chemical Characterization and In Vitro Bioactivity and Cellular Analysis.

Authors:  Sergio Alexandre Gehrke; Patricia Mazón; Leticia Pérez-Díaz; José Luis Calvo-Guirado; Pablo Velásquez; Juan Manuel Aragoneses; Manuel Fernández-Domínguez; Piedad N De Aza
Journal:  Materials (Basel)       Date:  2019-02-01       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.